BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 3
• 4
• 5
• 6
• 7
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Business

  Labcorp Announces 2023 First Quarter Results

  Labcorp (NYSE: LH), a leading global life sciences company, today announced results for the first quarter ended March 31, 2023, and updated full-year guidance.

  April 25, 2023

   · 

  22 min read
• Genetown

  Agios to Present at the RBC Capital Markets Global Healthcare Conference on May 16, 2023

  Agios Pharmaceuticals, Inc. today announced that the company is scheduled to present at the RBC Capital Markets Global Healthcare Conference on Tuesday, May 16, 2024, at 9 a.m. ET.

  April 25, 2023

   · 

  1 min read
• FineHeart Granted First Two Patents in China for the FLOWMAKER®

  FineHeart S.A announced that its first two patents have been granted in China by the CNIPA - China National Intellectual Property Administration -.

  April 25, 2023

   · 

  5 min read
• Breaking News: Syrebo® BCI Rehabilitation Assessment System Wins Red Dot and iF Awards Two Top Global Design Awards

  Recently, the Syrebo® BCI Rehabilitation Assessment System SY-HR10A, a product of Siyi Intelligence, has won two world-renowned design awards: the Red Dot Design Award and the iF Product Design Award, attracting widespread attention from the industry.

  April 25, 2023

   · 

  4 min read
• Deals

  Assertio Holdings, Inc. to Acquire Spectrum Pharmaceuticals, Inc. in All Stock and CVR Transaction

  Assertio Holdings, Inc. and Spectrum Pharmaceuticals, Inc. announced that they have entered into a definitive agreement pursuant to which Assertio will acquire all outstanding shares of Spectrum in an all-stock and contingent value rights transaction.

  April 25, 2023

   · 

  19 min read
• Business

  Centene Corporation Reports First Quarter 2023 Results

  Centene’s first quarter results were strong, reflective of continued positive momentum operationally and the beginning of another year of disciplined execution against our strategic framework.

  April 25, 2023

   · 

  28 min read
• Policy

  Insulet Announces FDA Clearance of Omnipod GO™, a First-of-its-Kind Basal-Only Insulin Pod, Further Simplifying Life for People with Type 2 Diabetes

  Insulet Corporation announced the FDA clearance of its latest innovation, Omnipod GO™, an insulin delivery device cleared for use for people with type 2 diabetes age 18 or older who would typically take daily injections of long-acting insulin.

  April 25, 2023

   · 

  3 min read
• Biotech Beach

  Axonics to Participate in Upcoming May 2023 Investor Conferences

  Axonics, Inc., a global medical technology company that is developing and commercializing novel products for the treatment of bladder and bowel dysfunction, is scheduled to participate in the following upcoming investor conferences: Event.

  April 25, 2023

   · 

  1 min read
• Genetown

  Micropep Demonstrates Excellent Field Efficacy for New Micropeptide Active Ingredient

  Micropep Technologies, the global leader in micropeptide technology, announced successful efficacy results of its new biofungicide micropeptide ingredient during the 2022 field testing season.

  April 25, 2023

   · 

  4 min read
• Biotech Bay

  CareDx Showcases Latest Advances Across AlloSeq Lab Products Portfolio at the 36th European Immunogenetics and Histocompatibility Conference

  CareDx, Inc. announced that it will showcase the latest developments across its AlloSeq®* portfolio during the 36th European Immunogenetics and Histocompatibility Conference taking place April 26-29 in Nantes, France.

  April 25, 2023

   · 

  6 min read